Summary
Johnson & Johnson (JNJ) filed an 8-K on January 25, 2022, primarily to report its fourth quarter and full-year 2021 financial results, which concluded on January 2, 2022. The press release and supplementary financial data included in this filing provide investors with key performance indicators, including sales and earnings. Investors should review these disclosures to understand the company's recent financial health and operational performance across its diverse business segments.
Key Highlights
- 1Johnson & Johnson announced its fourth quarter and full year 2021 financial results on January 25, 2022.
- 2The reporting period for these results ended on January 2, 2022.
- 3The 8-K filing includes a press release detailing sales and earnings.
- 4Supplementary unaudited comparative sales data and condensed consolidated statements of earnings are provided.
- 5This filing serves as the official vehicle for disseminating JNJ's most recent financial performance figures.
- 6Investors can use this information to assess the company's revenue generation and profitability trends.